Tags

Type your tag names separated by a space and hit enter

Vaccines and vaccination against tick-borne encephalitis.
Expert Rev Vaccines 2012; 11(9):1103-19ER

Abstract

Tick-borne encephalitis (TBE) is an emerging viral zoonosis and is endemic from Japan, China, Mongolia and Russia, to Central Europe and France. There is no specific treatment and TBE can be fatal. The four licensed prophylactic vaccines are produced according to WHO manufacturing requirements. Large clinical trials and postmarketing surveillance demonstrated safety and efficacy of the two European vaccines. The two Russian vaccines showed their effectiveness in daily use, but limited published data are available on controlled clinical trials. Vaccination recommendations in endemic areas vary significantly. In some countries, public vaccination programs are implemented. The WHO has recently issued recommendations on evidence-based use of TBE vaccines. However, more data are needed regarding safety, efficacy and long-term protection after vaccination.

Authors+Show Affiliations

Department of Specific Prophylaxis and Tropical Medicine, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Kinderspitalgasse 15, Vienna, Austria.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't
Review

Language

eng

PubMed ID

23151167

Citation

Kollaritsch, Herwig, et al. "Vaccines and Vaccination Against Tick-borne Encephalitis." Expert Review of Vaccines, vol. 11, no. 9, 2012, pp. 1103-19.
Kollaritsch H, Paulke-Korinek M, Holzmann H, et al. Vaccines and vaccination against tick-borne encephalitis. Expert Rev Vaccines. 2012;11(9):1103-19.
Kollaritsch, H., Paulke-Korinek, M., Holzmann, H., Hombach, J., Bjorvatn, B., & Barrett, A. (2012). Vaccines and vaccination against tick-borne encephalitis. Expert Review of Vaccines, 11(9), pp. 1103-19. doi:10.1586/erv.12.86.
Kollaritsch H, et al. Vaccines and Vaccination Against Tick-borne Encephalitis. Expert Rev Vaccines. 2012;11(9):1103-19. PubMed PMID: 23151167.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Vaccines and vaccination against tick-borne encephalitis. AU - Kollaritsch,Herwig, AU - Paulke-Korinek,Maria, AU - Holzmann,Heidemarie, AU - Hombach,Joachim, AU - Bjorvatn,Bjarne, AU - Barrett,Alan, PY - 2012/11/16/entrez PY - 2012/11/16/pubmed PY - 2013/4/18/medline SP - 1103 EP - 19 JF - Expert review of vaccines JO - Expert Rev Vaccines VL - 11 IS - 9 N2 - Tick-borne encephalitis (TBE) is an emerging viral zoonosis and is endemic from Japan, China, Mongolia and Russia, to Central Europe and France. There is no specific treatment and TBE can be fatal. The four licensed prophylactic vaccines are produced according to WHO manufacturing requirements. Large clinical trials and postmarketing surveillance demonstrated safety and efficacy of the two European vaccines. The two Russian vaccines showed their effectiveness in daily use, but limited published data are available on controlled clinical trials. Vaccination recommendations in endemic areas vary significantly. In some countries, public vaccination programs are implemented. The WHO has recently issued recommendations on evidence-based use of TBE vaccines. However, more data are needed regarding safety, efficacy and long-term protection after vaccination. SN - 1744-8395 UR - https://www.unboundmedicine.com/medline/citation/23151167/full_citation L2 - http://www.tandfonline.com/doi/full/10.1586/erv.12.86 DB - PRIME DP - Unbound Medicine ER -